Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
ConditionUterine Fibroid
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-50
SponsorInSightec
About this trial
The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.
Eligibility criteria
Qualifiers
- Eligibility is as per the symptomatic fibroids device indication. - All registry-consented patients following the treatment of their fibroid(s) with the Exablate system.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Body System - Functional
Treatment groups
200 Participants
are divided into 1 treatment groupLocations
6China
Huashan Hospital Affiliated to Fudan University Shanghai China
Shanghai No. 1 Hospital Shanghai China
Shanghai No.1 Hospital Shanghai China
United States
UCLA90095, Los AngelesCalifornia, United States
Sponsors and collaborators
InSightec
Lead sponsor
Source ClinicalTrials.gov